Clinical Trial Update: Study of CRS-207, Nivolumab, and Ipilimumab With or Without GVAX Pancreas Vaccine (With Cy) in Patients With Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update on combining CRS-207 with nivolumab and ipilimumab, with or without GVAX pancreas vaccine, in pancreatic cancer; the study completed and re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• CRS-207
• GVAX Pancreas Vaccine
• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-07-10